Pharma and Biotech
By Iain Gilbert
Date: Tuesday 09 Nov 2021
LONDON (ShareCast) - (Sharecast News) - Nanopore-based technology firm Oxford Nanopore Technologies updated its full-year revenue guidance on Tuesday following a "significant expansion" of its activities in a large customer project in the United Arab Emirates.
Oxford Nanopore said on Tuesday that it had been awarded a new 36-month contract with G42 Laboratory, under which it will provide devices, consumables and other support services worth approximately $68.0m.
The London-listed group stated the project was expected to generate revenues primarily after the year-end. Therefore, it opted to maintain its guidance for core life science research tools revenues (LSRT) of £105.0m-111.0m in 2021.
However, given the scale of the new contract, Oxford Nanopore said it was now introducing guidance for LSRT revenues of £135.0m-145.0m for the 2022 trading year and also upgraded its LSRT revenue guidance for 2023 to £170.0m-190.0m.
As of 0915 GMT, Oxford Nanopore shares were 5.41% at 575.0p.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 110.10p |
Change Today | 3.70p |
% Change | 3.48 % |
52 Week High | 275.00 |
52 Week Low | 92.75 |
Volume | 1,156 |
Shares Issued | 862.59m |
Market Cap | £949.71m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:19 | 15 @ 111.50p |
17:07 | 9,900 @ 110.10p |
16:47 | 27,881 @ 109.57p |
16:37 | 500,000 @ 109.08p |
16:35 | 216,469 @ 110.10p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research